Oncopro Prostate Cancer Screen Test Price 5620 AED in Dubai
Understanding the Oncopro Prostate Cancer Screen Test
Prostate cancer is a common and potentially life-threatening condition that affects men worldwide. Early detection is crucial for successful treatment, and the Oncopro Prostate Cancer Screen Test is a reliable tool designed to identify prostate cancer in its early stages. This article provides an in-depth look at the Oncopro Prostate Cancer Screen Test, its benefits, and why it is essential for men in the UAE.
What is the Oncopro Prostate Cancer Screen Test?
The Oncopro Prostate Cancer Screen Test is a diagnostic tool that measures the levels of prostate-specific antigen (PSA) in the blood. PSA is a protein produced by the prostate gland, and elevated levels can indicate the presence of prostate cancer. This test is particularly useful for men with gray zone Total PSA levels (4-10 ng/mL), helping physicians decide if a biopsy is necessary
Importance of Early Detection
Prostate cancer often does not produce noticeable symptoms in its early stages. However, as the cancer progresses, symptoms such as frequent urination, difficulty starting or stopping urination, weak or interrupted urine flow, blood in the urine or semen, and pain or discomfort in the pelvic area may occur
. Early detection through screening tests like the Oncopro Prostate Cancer Screen Test can significantly improve treatment outcomes.
How Does the Test Work?
The Oncopro Prostate Cancer Screen Test involves a simple blood test that measures PSA levels. If the PSA levels are elevated, further diagnostic tests such as a digital rectal exam, biopsy, or imaging tests may be recommended to confirm the presence of cancer.
Benefits of the Oncopro Prostate Cancer Screen Test
- Early Detection: The test helps in early detection of prostate cancer, which is crucial for successful treatment.
- Reduced Mortality: Studies have shown that men who undergo prostate cancer screening have a reduced risk of dying from the disease.
- Accurate Diagnosis: The test is accurate and convenient, helping physicians discriminate between cancer and non-cancer in patients with gray zone PSA levels.
Who Should Get Tested?
Every man over the age of 45 should attend routine prostate cancer screening. If you have additional risk factors such as a family history of prostate cancer or are overweight, screening should begin earlier.
Current Trends and Expert Opinions
Recent studies emphasize the importance of prostate cancer screening. The long-term results from the European Randomized Study of Screening for Prostate Cancer (ERSPC) study showed that PSA screening significantly reduced prostate cancer mortality.
. Experts at Cleveland Clinic Abu Dhabi recommend regular screenings for men over 40 to catch prostate cancer early, when it is often curable.
Conclusion
The Oncopro Prostate Cancer Screen Test is a valuable tool for diagnosing prostate cancer in its early stages. Given the high incidence rates of prostate cancer in the UAE and the importance of early detection, it is essential for men in the region to consider regular screening. By understanding the benefits and process of the Oncopro Prostate Cancer Screen Test, individuals can take proactive steps towards their health and well-being.
At DNA Labs UAE, we offer the ONCOPRO Prostate Cancer Screen Test to detect and monitor prostate cancer. This blood test measures the levels of prostate-specific antigen (PSA) in a man’s blood, which can indicate the presence of prostate cancer.
Test Details
The ONCOPRO Prostate Cancer Screen Test is recommended for men over the age of 50 or for those with a family history of prostate cancer. It is not a definitive test for prostate cancer, but rather a screening tool to assess the risk of developing the disease.
The test involves collecting a sample of 8 mL of whole blood in a Lavender Top (EDTA) tube, which is provided in a sample collection kit available from DNA Labs UAE. The preservative supplied in the kit should be added to the EDTA tube using a syringe and needle. The sample should be shipped immediately at a temperature of 18-22°C and should not be refrigerated or frozen.
It is mandatory to fill out the OncoPro Prostate Cancer Screen Clinical Information Form (Form 30) before undergoing the test. This form provides important information for the accurate interpretation of the test results.
Test Cost and Report Delivery
The cost of the ONCOPRO Prostate Cancer Screen Test is AED 5620.0. The report will be delivered within 21 working days from the date of sample collection.
Test Method and Components
The ONCOPRO Prostate Cancer Screen Test involves extraction and staining techniques to measure the levels of PSA in the blood. PSA is a protein produced by the prostate gland, and elevated levels can indicate the presence of prostate cancer.
Post Test Information
If the test results indicate a high level of PSA, further testing such as a biopsy may be recommended to confirm the presence of prostate cancer. It is important for men to discuss the risks and benefits of prostate cancer screening with their healthcare provider to determine if the ONCOPRO Prostate Cancer Screen Test is appropriate for them.
Remember, a positive result does not necessarily mean that a man has prostate cancer, and a negative result does not necessarily mean that a man does not have prostate cancer. The ONCOPRO Prostate Cancer Screen Test is a valuable tool in assessing the risk of prostate cancer, but further diagnostic procedures may be required for a definitive diagnosis.
For more information or to schedule an appointment for the ONCOPRO Prostate Cancer Screen Test, please contact DNA Labs UAE.
Test Name | ONCOPRO PROSTATE CANCER SCREEN Test |
---|---|
Components | |
Price | 5620.0 AED |
Sample Condition | 8 mL whole bloodin 1 Lavender Top (EDTA) tube in sample collection kit available from LPL. Add the preservative supplied in the kit to the EDTA tube using a syringe & needle. Ship immediately at 18\u0192??22?\u00f8C. DO NOT REFRIGERATE OR FREEZE. Duly filled OncoPro Prostate Cancer Screen Clinical Information Form (Form 30)is mandatory. |
Report Delivery | 21 Working Days |
Method | Extraction, Staining |
Test type | Cancer |
Doctor | Oncologist |
Test Department: | MOLECULAR DIAGNOSTICS |
Pre Test Information | Duly filled OncoPro Prostate Cancer Screen Clinical Information Form (Form 30)is mandatory. |
Test Details | The ONCOPRO Prostate Cancer Screen Test is a blood test that measures the levels of prostate-specific antigen (PSA) in a man’s blood. PSA is a protein produced by the prostate gland, and high levels of PSA can indicate the presence of prostate cancer.
The test is typically recommended for men over the age of 50 or for men who have a family history of prostate cancer. The test can also be used to monitor the progression of prostate cancer in men who have already been diagnosed. It is important to note that the ONCOPRO Prostate Cancer Screen Test is not a definitive test for prostate cancer. A positive result does not necessarily mean that a man has prostate cancer, and a negative result does not necessarily mean that a man does not have prostate cancer. If the test results indicate a high level of PSA, further testing, such as a biopsy, may be recommended to confirm the presence of prostate cancer. It is important for men to discuss the risks and benefits of prostate cancer screening with their healthcare provider to determine if the ONCOPRO Prostate Cancer Screen Test is appropriate for them. |